NSD1 Inactivation and SETD2 Mutation Drive a Convergence Toward Loss-Of-Function of H3K36 Writers in Clear-Cell Renal Cell Carcinomas

Cancer Research - United States
doi 10.1158/0008-5472.can-17-0143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

miR-106b-5p Targets Tumor Suppressor Gene SETD2 to Inactive Its Function in Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2015English

Primary Renal Carcinoid With Bilateral Multiple Clear Cell Papillary Renal Cell Carcinomas

Case Reports in Pathology
2017English

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)

PLoS ONE
Multidisciplinary
2015English

HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas

Cancer Research
Cancer ResearchOncology
2017English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Molecular Genetics of Clear-Cell Renal Cell Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Alteration of ASIC1 Expression in Clear Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2015English

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Molecular Genetic Diagnostics of Clear Cell Renal Cell Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy